🇺🇸 FDA
Patent

US 11884932

In vitro production of medial ganglionic eminence precursor cells

granted A61PA61P25/00

Quick answer

US patent 11884932 (In vitro production of medial ganglionic eminence precursor cells) held by The Regents of the University of California expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P25/00